LAGI, FILIPPO
 Distribuzione geografica
Continente #
NA - Nord America 3.052
AS - Asia 2.822
EU - Europa 2.721
SA - Sud America 325
AF - Africa 55
OC - Oceania 41
Totale 9.016
Nazione #
US - Stati Uniti d'America 3.016
RU - Federazione Russa 1.322
SG - Singapore 923
CN - Cina 875
IT - Italia 463
HK - Hong Kong 392
KR - Corea 313
BR - Brasile 260
PL - Polonia 250
IE - Irlanda 160
DE - Germania 134
SE - Svezia 118
VN - Vietnam 106
FI - Finlandia 73
GB - Regno Unito 62
IN - India 60
FR - Francia 54
JO - Giordania 44
AU - Australia 40
ID - Indonesia 38
AR - Argentina 29
NL - Olanda 23
CA - Canada 18
ES - Italia 15
MX - Messico 14
ZA - Sudafrica 13
EC - Ecuador 12
UA - Ucraina 12
CH - Svizzera 11
BJ - Benin 9
JP - Giappone 9
CI - Costa d'Avorio 8
CO - Colombia 8
RO - Romania 8
TR - Turchia 8
BD - Bangladesh 7
PY - Paraguay 7
CL - Cile 5
ET - Etiopia 5
PH - Filippine 5
PK - Pakistan 5
UZ - Uzbekistan 5
IQ - Iraq 4
KE - Kenya 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
EG - Egitto 3
LT - Lituania 3
MA - Marocco 3
SA - Arabia Saudita 3
TN - Tunisia 3
TW - Taiwan 3
VE - Venezuela 3
AM - Armenia 2
DZ - Algeria 2
EE - Estonia 2
IR - Iran 2
LU - Lussemburgo 2
NP - Nepal 2
AO - Angola 1
AT - Austria 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BG - Bulgaria 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
MK - Macedonia 1
MY - Malesia 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TO - Tonga 1
TT - Trinidad e Tobago 1
UG - Uganda 1
UY - Uruguay 1
YT - Mayotte 1
Totale 9.016
Città #
Santa Clara 1.042
Singapore 674
Ashburn 454
Hefei 376
Hong Kong 341
Seoul 311
Warsaw 245
Dublin 160
Fairfield 126
Florence 119
Chandler 109
Dallas 95
Beijing 94
Moscow 81
Munich 78
Los Angeles 67
Buffalo 60
Kent 56
Altamura 50
Lawrence 50
Seattle 43
Houston 39
Melbourne 39
New York 39
Woodbridge 39
Wilmington 38
Ho Chi Minh City 37
Cambridge 34
Helsinki 34
Paris 34
Mumbai 33
Jakarta 31
Milan 31
Princeton 31
Hanoi 27
São Paulo 26
London 25
Boston 21
Rome 21
Turku 21
Bengaluru 16
Medford 16
Shanghai 16
San Diego 14
Lappeenranta 13
The Dalles 13
Ann Arbor 12
Chicago 12
West Jordan 12
Denver 11
Redondo Beach 11
Frankfurt am Main 10
Poplar 10
Rio de Janeiro 10
Yubileyny 10
Bern 9
Brooklyn 9
Cotonou 9
Montreal 9
Naples 9
Phoenix 9
Tokyo 9
Abidjan 8
Dearborn 8
Falkenstein 7
Guangzhou 7
Madrid 7
Timisoara 7
Clifton 6
Dong Ket 6
Düsseldorf 6
Johannesburg 6
Nuremberg 6
Orem 6
Pistoia 6
San Jose 6
Washington 6
Andover 5
Belo Horizonte 5
Da Nang 5
Manaus 5
Overland Park 5
Pune 5
Stockholm 5
Tashkent 5
Tianjin 5
Tizzana 5
Warder 5
Amman 4
Arezzo 4
Atlanta 4
Boardman 4
Bremen 4
Cagliari 4
Camparada 4
Campi Bisenzio 4
Chennai 4
Curitiba 4
Elk Grove Village 4
Guarulhos 4
Totale 5.681
Nome #
Proposal for a New Score-Based Approach To Improve Efficiency of Diagnostic Laboratory Workflow for Acute Bacterial Meningitis in Adults 421
Imported dengue fever in Tuscany, Italy, in the period 2006 to 2012. 213
Antibodies Induced by Smallpox Vaccination after at Least 45 Years Cross-React with and In Vitro Neutralize Mpox Virus: A Role for Polyclonal B Cell Activation? 191
Early experience of an infectious and tropical diseases unit during the coronavirus disease (COVID-19) pandemic, Florence, Italy, February to March 2020 173
Latent Tuberculosis Infection and COVID-19: Analysis of a Cohort of Patients from Careggi University Hospital (Florence, Italy) 168
Implementing Early Phase Treatments for COVID-19 in Outpatient Settings: Challenges at a Tertiary Care Center in Italy and Future Outlooks 166
Prevalence and Correlates of Sexually Transmitted Infections in Transgender People: An Italian Multicentric Cross-Sectional Study 161
Reply: COVID-19: Semen impairment may not be related to the virus 160
Results of comprehensive cardiovascular diagnostic work-up in HIV positive patients 159
Early discharge criteria in patients with acute bacterial skin and skin structure infections in a large tertiary-care teaching hospital in Florence, Italy 156
Use of the FebriDx point-of-care test for the exclusion of SARS-CoV-2 diagnosis in a population with acute respiratory infection during the second (COVID-19) wave in Italy 153
First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19 151
Cancer population may be paradoxically protected from severe manifestations of COVID-19 150
Arbo-score: A rapid score for early identification of patients with imported arbovirosis caused by Dengue, Chikungunya and zika virus 150
Characteristics of COVID-19 vaccinated and unvaccinated patients admitted to Careggi University Hospital, Florence, Italy 149
Male reproductive system inflammation after healing from coronavirus disease 2019 149
Effects of viremia and CD4 recovery on gut "microbiome-immunity" axis in treatment-naïve HIV-1-infected patients undergoing antiretroviral therapy 146
Treatment with anti-SARS-CoV-2 monoclonal antibodies in pregnant and postpartum women: first experiences in Florence, Italy 146
Seasonal Allergic Rhinitis Symptoms in Relation to COVID-19 146
Can SSRI/SNRI antidepressants decrease the 'cytokine storm' in the course of COVID-19 pneumonia? 144
Cefiderocol use for the treatment of infections by carbapenem-resistant Gram-negative bacteria: an Italian multicentre real-life experience 142
Tubercular prosthetic joint infection: two case reports and literature review 139
Diagnostic accuracy of physician’s gestalt in suspected COVID-19: Prospective bicentric study 138
The prognostic role of IL-10 in non-severe COVID-19 with chemosensory dysfunction 136
Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary Study 134
The never-ending story of mpox epidemic: Tracing a new cluster in Florence, Italy 133
Emergence of dengue fever: sentinel travellers uncover outbreak in Sharm El-Sheikh, Egypt, May 2024 133
When it rains, it pours: Early treatment with tecovirimat of cardiac complications associated with monkeypox infection in a person with HIV and previously undiagnosed Lyme disease. A case report 133
Semen impairment and occurrence of SARS-CoV-2 virus in semen after recovery from COVID-19 133
DYNAMIC OF TRANSMISSION AND ACQUISITION OF HIV AMONG MIGRANTS FROM PERU LIVING IN FLORENCE: IMPLICATIONS FOR EFFECTIVELY MANAGING HIV PREVENTION AND RETENTION PROGRAMMES 132
Facilitators and barriers in HIV testing and continuum of care among migrant transgender women who are sex workers residing in Florence, Italy 129
Long-term maintenance of virologic suppression in native and migrant HIV-1 naïve patients: an Italian cohort study 129
High-dose steroids for the treatment of severe COVID-19 126
SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes: implications for booster strategies 125
Oral microbiota signatures associated with viremia and CD4 recovery in treatment-naïve HIV-1-infected patients 122
Continuum of care among HIV-1 positive patients in a single center in Italy (2007–2017) 122
Leptospirosis acquired by tourists in Venice, Italy 119
Early discontinuation of DTG/ABC/3TC and BIC/TAF/FTC single-tablet regimens: a real-life multicenter cohort study 118
Safety and Efficacy of Outpatient Treatments for COVID-19: Real-Life Data from a Regionwide Cohort of High-Risk Patients in Tuscany, Italy (the FEDERATE Cohort) 118
Procalcitonin for the differential diagnosis of COVID-19 in the emergency department. Prospective monocentric study 116
Comparison of the efficacy, safety and durability of a switch to co-formulated RPV/TDF-TAF/FTC or DTG/ABC/3TC in virologically-suppressed HIV-1-infected patients in a single Italian centre: a cohort data analysis 113
Babesiosis in the immunocompromised population: Results from a multicentric cohort study conducted in Italy 112
Efficacy and safety of Pentamidine isethionate for tegumentary and visceral human leishmaniasis: a systematic review 112
Prospective study on incidence, risk factors and outcome of recurrent clostridioides difficile infections 110
A comparison between two dolutegravir-based two-drug regimens as switch strategies in a multicentre cohort of HIV-1-infected patients 109
Use of colistin in adult patients: A cross-sectional study 108
Polypharmacy, anticholinergic burden and drug–drug interaction assessment in people with four-class-resistant HIV: data from the PRESTIGIO registry 107
Fourth Dose of mRNA COVID-19 Vaccine Transiently Reactivates Spike-Specific Immunological Memory in People Living with HIV (PLWH) 107
Clinical role of viral identification by a polymerase chain reaction-based diagnostic panel in adults hospitalized with community-acquired pneumonia 104
Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort 101
Risk factors for extended-spectrum beta-lactamase-producing Enterobacteriales infection: are they the same in neutropenic and non-neutropenic patients? 101
The burden of clostridioides difficile infection during the COVID-19 pandemic: A retrospective case-control study in Italian hospitals (CloVid) 100
Imported dengue fever in Tuscany, Italy, in the period 2006 to 2012. 100
Impact of rapid-antiretroviral therapy in a cohort of treatment-naïve migrants living with HIV in a high income setting 97
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry 97
Overall Tolerability of Integrase Inhibitors in Clinical Practice: Results from a Multicenter Italian Cohort 95
Efficacy and safety of dolutegravir-based regimens in advanced HIV-infected naïve patients: results from a multicenter cohort study 95
Cohort profile: The Observational cohort for the study of DOlutegravir in Antiretroviral Combination REgimens (ODOACRE) 94
Analysing the efficacy and tolerability of dolutegravir plus either rilpivirine or lamivudine in a multicentre cohort of virologically suppressed PLWHIV 94
Efficacy and Durability of Dolutegravir- or Darunavir-Based Regimens in ART-Naïve AIDS- or Late-Presenting HIV-Infected Patients 92
Incidence of hypoglycaemia associated with transient loss of consciousness. A retrospective cohort study 87
Prevalence and determinants of resistance mutations in HIV-1-infected patients exposed to integrase inhibitors in a large Italian cohort 87
Real-Life Impact of Drug Toxicity on Dolutegravir Tolerability: Clinical Practice Data from a Multicenter Italian Cohort 84
UNAIDS 90-90-90 Target and Retention in Care of a Cohort of Migrants Living with HIV in a Tertiary Referral Hospital in Florence, Italy 84
Monkeypox: A novel pitfall in clinical dermatology 78
Viro-immunological efficacy and tolerability of dolutegravir-based regimens compared to regimens based on other integrase strand inhibitors, protease inhibitors or non-nucleoside reverse transcriptase inhibitors in patients with acute HIV-1 infection: A multicenter retrospective cohort study 78
Malattie Tropicali Neglette in un'area non endemica, la casistica del Centro di Riferimento della Regione Toscana per lo Studio e la Cura delle Malattie Tropicali (1999-2013) 78
Has COVID-19 changed the approach to HIV diagnosis?: A multicentric Italian experience 77
Two-fold increased risk of cardiovascular events in people with MDR HIV: a matched cohort analysis with data from the PRESTIGIO registry 75
Transgender people living with HIV: characteristics and comparison to homosexual and heterosexual cisgender patients in two Italian teaching hospitals 71
VIRO-immunological response of drug-naive HIV-1-infected patients starting a first-line regimen with viraemia >500,000 copies/ml in clinical practice 69
Single tablet regimen with abacavir/lamivudine/dolutegravir compared with two-drug regimen with lamivudine and dolutegravir as different strategies of simplification from a multicenter HIV cohort study 69
Efficacy and safety of switching to dolutegravir plus emtricitabine/tenofovir disoproxil fumarate (TDF) or elvitegravir/cobicistat/emtricitabine/TDF in virologically suppressed HIV-infected patients in clinical practice: results from a multicentre, observational study 65
Serology-Based Screening and Prevalence of Schistosomiasis, Strongyloidiasis, and Chagas Disease in Migrants Living with HIV: Results from a 10-Year Retrospective Cohort in an Italian Tertiary Healthcare Center 10
Screening for Leishmania spp. infection in patients treated with biologic agents for immune-mediated inflammatory diseases: results of an Italian multicentric prospective study 10
Exploring mpox vaccination uptake and tolerability among people living with HIV: A study in an infectious disease unit in Italy 7
Totale 9.106
Categoria #
all - tutte 29.461
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.461


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021153 0 0 0 0 0 31 8 15 31 17 15 36
2021/2022229 10 17 13 10 4 24 4 28 5 13 32 69
2022/2023723 45 151 44 20 26 120 100 43 88 13 53 20
2023/2024687 21 41 68 30 46 88 21 170 24 99 52 27
2024/20253.731 130 356 217 627 934 440 115 167 195 123 167 260
2025/20263.103 588 739 723 461 575 17 0 0 0 0 0 0
Totale 9.106